Please login to the form below

Not currently logged in

Sandra Carey takes on global president, expert audiences role at McCann Health

Internal promotion sees Carey take the helm of McCann's expert audience practice

McCann Health has promoted Sandra Carey to the new role of global president, expert audiences.

Prior to her promotion, Carey served as global president, McCann Health pharmacy marketing.

Before joining McCann, Carey held leadership positions in retail, international and national regulatory bodies.

She has also been a practising pharmacist and practitioner for most of her career, working as a clinical pharmacist in a family practice setting, running diabetes and pain management clinics and more.

Carey has also served as a key resource to pharmaceutical organisations, consulting on a number of areas of the business of pharmacy, regulatory landscapes and practice models involving pharmacists, technicians and assistants integration into multidisciplinary teams.

In her new role at McCann, she will work with a team of healthcare extenders across the network to bring insights, understanding and meaningful programmes to the company's clients.

Article by
Lucy Parsons

12th January 2021

From: Marketing


Subscribe to our email news alerts

Featured jobs


Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Lifting the fog to help Clinical Labs navigate IVDR 2022
In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests. BD wanted to let their...
Empowering adolescents to manage emotional and mental health issues
1 in 10 UK children suffer with a mental health issue and alarmingly as many as 70% of these don’t receive the proper support they need. That’s why The Anna...
Reframing rare to increase earlier diagnosis of Gaucher Disease
Sanofi Genzyme wanted to reach haematologists; the specialist physicians most likely to encounter patients with Gaucher Disease prior to diagnosis. The problem? Gaucher Disease is considered very rare and its...